BRWA
VNRX icon

B. Riley Wealth Advisors’s VolitionRx Ltd VNRX Stock Holding History

B. Riley Wealth Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-600
Closed -$38K – 655
2016
Q2 		$38K Buy
+600
New +$41.4K 0.01% 604

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

B. Riley Wealth Advisors's VNRX Position: Q3 2016 in Review

B. Riley Wealth Advisors sold out of VolitionRx Ltd (VNRX) in Q3 2016, closing a stake of 600 shares — an estimated $38K sold.

B. Riley Wealth Advisors first reported a position in VNRX in Q2 2016 and held it in 1 quarter. The position peaked at $38K in Q2 2016. 16 funds tracked by Wall St. Rank hold VNRX as of Q3 2016.

  • B. Riley Wealth Advisors reported no remaining VolitionRx Ltd position as of Q3 2016 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 600 VolitionRx Ltd shares in Q3 2016, an estimated $38K.
  • B. Riley Wealth Advisors first reported a position in VolitionRx Ltd in Q2 2016 and held it in 1 quarter.
  • B. Riley Wealth Advisors's VolitionRx Ltd position peaked at $38K in Q2 2016.
  • 16 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2016.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.